A citation-based method for searching scientific literature

Lekha Mikkilineni, James N Kochenderfer. Nat Rev Clin Oncol 2021
Times Cited: 80

Nina Shah, Ajai Chari, Emma Scott, Khalid Mezzi, Saad Z Usmani. Leukemia 2020
Times Cited: 139

List of shared articles

Times cited

An update on B-cell maturation antigen-targeted therapies in Multiple Myeloma.
Massimo Martino, Annalisa Paviglianiti. Expert Opin Biol Ther 2021

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation.
Hailin Chen, Tengteng Yu, Liang Lin, Lijie Xing, Shih-Feng Cho, Kenneth Wen, Kimberly Aardalen, Adwait Oka, Joni Lam, Mike Daley,[...]. Blood Cancer J 2022

Clinical experience of CAR T cells for multiple myeloma.
Gary L Simmons, Toshihisa Satta, Omar Castaneda Puglianini. Best Pract Res Clin Haematol 2021

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM.
Hyunkyung Park, Ja Min Byun, Sung-Soo Yoon, Youngil Koh, Sock-Won Yoon, Dong-Yeop Shin, Junshik Hong, Inho Kim. PLoS One 2022

When and How to Treat Relapsed Multiple Myeloma.
Nitya Nathwani, Luca Bertamini, Rahul Banerjee, Francesca Gay, Nina Shah, Amrita Krishnan. Am Soc Clin Oncol Educ Book 2021

Emerging new therapeutic antibody derivatives for cancer treatment.
Shijie Jin, Yanping Sun, Xiao Liang, Xinyu Gu, Jiangtao Ning, Yingchun Xu, Shuqing Chen, Liqiang Pan. Signal Transduct Target Ther 2022

Bispecific antibodies for non-Hodgkin's lymphomas and multiple myeloma.
Omar Castaneda-Puglianini, Julio C Chavez. Drugs Context 2021

T-Cell-Based Cellular Immunotherapy of Multiple Myeloma: Current Developments.
Gary L Simmons, Omar Castaneda Puglianini. Cancers (Basel) 2022